ALOPECIA
Clinical trials for ALOPECIA explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA trials appear
Sign up with your email to follow new studies for ALOPECIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New scalp formula shows promise for hair regrowth in small study
Disease control CompletedThis study tested a special mineral-ionic formula called THERAVEX REGENERA in 20 adults with hair loss. The treatment was used during hair transplant procedures and as a scalp therapy to help hair follicles grow back. Researchers checked safety and measured changes in hair densit…
Matched conditions: ALOPECIA
Phase: NA • Sponsor: Biointelligent Technology Systems SL • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Pill vs. needle: can roflumilast regrow hair in alopecia areata?
Disease control CompletedThis completed trial tested whether an oral anti-inflammatory drug called roflumilast can regrow hair as well as steroid injections in people with mild-to-moderate patchy alopecia areata. Fifty adults with limited to moderate hair loss were enrolled. The main goal was to measure …
Matched conditions: ALOPECIA
Phase: PHASE4 • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 26, 2026 17:01 UTC
-
AI boosts skin diagnosis accuracy in small trial
Diagnosis CompletedThis completed study tested whether an AI device could help 16 doctors (10 general practitioners and 6 dermatologists) more accurately diagnose 13 different skin conditions, including melanoma, psoriasis, and acne. The doctors reviewed 29 medical images, first giving a diagnosis …
Matched conditions: ALOPECIA
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
Cooling caps may keep hair on during pancreatic cancer chemo
Symptom relief CompletedThis pilot study tested a scalp cooling device (Paxman) to prevent hair loss in 9 people with advanced pancreatic cancer receiving chemotherapy. The goal was to see if the cap could keep hair loss mild (less than 50% hair loss) and improve comfort. Results focused on hair preserv…
Matched conditions: ALOPECIA
Phase: NA • Sponsor: HonorHealth Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Scientists test designer immune molecules in autoimmune diseases
Knowledge-focused CompletedThis study looked at whether specially engineered versions of a natural immune protein (IL-2) can selectively boost regulatory T cells, which help calm the immune system. Researchers took blood samples from 67 people with various autoimmune or inflammatory conditions and tested t…
Matched conditions: ALOPECIA
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC